Skip to main content

M Mar Mañu Pereira

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

M Mar Mañu Pereira

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Head of research Lab in rare anemia disorders - Senior researcher Scientific Director of ERN-EuroBloodNet Coordinator of the European platforms for patients registries in hematology ENROL and in rare anemia disorders RADeep

Head of research Lab in rare anemia disorders at VHIR - 2018 - Currently
Institut de Recerca contra la Leucèmia Josep Carreras - 2016-2018
Institut d'Investigacions Biomèdiques August Pi i Sunyer / Hospital Clínic de Barcelona - 2002-2016
Dr in BioMedicine 2009

Projects

HemaFAIR: Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases

IP: M Mar Mañu Pereira
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 221875
Reference: HEMAFAIR/EC/WIDERA-2023-ACCESS-02-01/2023/MAÑU
Duration: 01/06/2024 - 30/06/2027

RealiseD: Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases

IP: M Mar Mañu Pereira
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 188587.5
Reference: REALISED
Duration: 01/01/2025 - 31/12/2029

TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas

IP: Begoña Benito Villabriga
Collaborators: Carmen Escudero Iriarte, Laia Ventura i Expósito, Susana Otero Romero, Ignacio Ferreira González, José Antonio Barrabés Riu, Carlos Nos Llopis, Pablo Velasco Puyó, Jose Fernando Rodríguez Palomares, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Belen Perez Dueñas, Jaume Sastre Garriga, Joan López Hellin, Antonia Sambola Ayala, Jordi Rio Izquierdo, Nuria Rivas Gandara, Jordi Perez Rodon, Aroa Soriano Fernández, Manuel Comabella Lopez, Antonio Rodríguez Sinovas, Gisela Teixido Tura, Antonia Pijuan Domenech, Roser Ferrer Costa, Joaquin Seras Franzoso, Carmen Tur Gomez, Maria Cristina Díaz de Heredia Rubio, Laia Yañez Bisbe, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Miguel Segura Ginard, Diego Baranda Martínez-Abasca, Cristina Auger Acosta, Neus Bellera Gotarda, Teresa Macarulla Mercadé, Herena Eixarch Ahufinger, M Mar Mañu Pereira, Deborah Pareto Onghena, Lorena Valero Arrese, Aitor Uribarri Gonzalez, Jordi Bañeras Rius, Alex Rovira Cañellas, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Bruno Garcia del Blanco, Ana Vivancos Prellezo, Maria Teresa Salcedo Allende, Marisol Ruiz Meana, Ana Belén Méndez Fernández, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Simon Schwartz Navarro, Anna Llort Sales, Carmen Espejo Ruiz, Raquel Hladun Alvaro, Sandra Mancilla Zamora, Ana Zabalza de Torres, Javier Inserte Igual, Luciana Midaglia Fernandez, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Gabriela Guillén Burrieza, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, David Gómez Andrés, Alvaro Cobo Calvo, Alvaro Calabuig Goena, Joaquin Castillo Justribo, Lydia Dux-Santoy Hurtado, Lucas Moreno Martín-Retortillo, Andres Miguez Gonzalez, Josep Roma Castanyer, Laura Dos Subirá, Nicolás Miguel Fissolo , Maria Nazarena Pizzi, Paolo Giovanni Nuciforo, Tian Tian, Diana Fernandes de Rafael, Andrea Guala
Funding agency: Instituto de Salud Carlos III
Funding: 2494527.53
Reference: FORT23/00034
Duration: 01/01/2024 - 31/12/2027

ERN-EuroBloodNet: EUROPEAN REFERENCE NETWORK ON RARE HEMATOLOGICAL DISEASES

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Claire Diot, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 371825
Reference: EUROBLOODNETBR2022_EU4H-ERN2022
Duration: 01/05/2022 - 30/11/2023

Related news

The Scientific Coordinator of ERN-EuroBloodNet will lead for one year the group that defines the common strategy of the European Reference Networks to improve care for rare and complex diseases.

Vall d’Hebron participates as a reference centre in Spain for early-phase clinical trials and coordinates the national ReALLNet network, promoting research into relapsed acute lymphoblastic leukemia.

The PHOENIX project, involving 13 European institutions, will evaluate for the first time in paediatric patients the drug ibrilatazar from AbilityPharma in a phase I/II clinical trial.

Related professionals

Rosa Maria Gracia Gozalo

Rosa Maria Gracia Gozalo

Senior researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Marta Machado Rosillo

Marta Machado Rosillo

Research technician
Shock, Organ Dysfunction and Resuscitation
Read more
Francisco Vidal Pérez

Francisco Vidal Pérez

Head of group
Transfusional Medicine
Read more
Judith Salat Batlle

Judith Salat Batlle

Research technician
Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.